Dr. Rotkis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
621 Memorial Dr
South Bend, IN 46601Phone+1 574-236-1888Fax+1 574-236-1887
Education & Training
Akron General Medical Center/NEOMEDResidency, Surgery, 1995 - 2000
The University of Toledo College of MedicineClass of 1995
Certifications & Licensure
IN State Medical License 2000 - 2025
OH State Medical License 1997 - 1998- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Publications & Presentations
PubMed
- 31 citationsPertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).Peter D. Beitsch, Pat Whitworth, Paul L. Baron, Michael Rotkis, Angela Mislowsky
Annals of Surgical Oncology. 2017-04-26
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
